Nuclear DNA and mitochondrial DNA guanine N7 sites (DNA N7-G)

The N7 position of guanine is the most nucleophilic site in DNA and serves as a critical target for various antineoplastic agents, including alkylating agents and platinum-based drugs (Source: PubChem, Alkylating Agents). These agents form covalent bonds with the N7 nitrogen, creating DNA adducts that disrupt the double helix structure and impede essential processes such as replication and transcription (Source: PubMed, PMID: 15057243). In nuclear DNA, this damage triggers the DNA damage response and can lead to programmed cell death (apoptosis), which is the basis for their use in treating various cancers (Source: NIH, National Cancer Institute). Mitochondrial DNA is also susceptible to these modifications, which can impair mitochondrial respiration and contribute to the systemic toxicity and side effects associated with these therapies (Source: Frontiers in Genetics, doi: 10.3389/fgene.2019.00153). The efficacy of drugs targeting these sites is often influenced by the cell's ability to repair the resulting damage through pathways like base excision repair or nucleotide excision repair (Source: Nature Reviews Cancer, doi: 10.1038/nrc2129). Because these drugs target DNA non-specifically across the genome, they are particularly effective against rapidly dividing cells but also cause significant damage to healthy tissues. Understanding the interaction at the N7 site is fundamental to the development of chemotherapy and the study of environmental mutagenesis.

Other names

N7-guanineGuanine N7 positionDNA N7-alkylguanine sitesN7-methylguanine sitesGuanine N7 alkylation sites

Covalent alkylation or platination at the N7 position of guanine bases, leading to the formation of DNA adducts, interstrand or intrastrand cross-links, and subsequent inhibition of DNA synthesis and induction of apoptosis (Source: Goodman & Gilman's The Pharmacological Basis of Therapeutics).